2020
DOI: 10.1007/s10529-020-02886-1
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of stem cells for treatment of neurodegenerative diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 273 publications
0
17
0
Order By: Relevance
“…Cell-based therapy, which may provide structural and functional reconstruction in brain regions, is a potential strategy for neurodegenerative diseases (Table 1 ) [ 20 , 44 , 45 ]. In HD, these related studies have been examined in different animal models.…”
Section: Huntington’s Diseasementioning
confidence: 99%
“…Cell-based therapy, which may provide structural and functional reconstruction in brain regions, is a potential strategy for neurodegenerative diseases (Table 1 ) [ 20 , 44 , 45 ]. In HD, these related studies have been examined in different animal models.…”
Section: Huntington’s Diseasementioning
confidence: 99%
“…Repairing the neural circuit by replacement of the dysfunctional neurons would represent an effective cure for neurodegenerative disorders. Nowadays, based on stem cell transplantation, neural stem cells which possess self-renewal and pluripotency have become a promising curative agent for neurodegenerative disorders treatment ( Lindvall et al, 2004 ; McGinley et al, 2018 ; Reidling et al, 2018 ; Song et al, 2018 ; Yang et al, 2018 ; Ahmadian-Moghadam et al, 2020 ; Derakhshankhah et al, 2020 ; Xapelli et al, 2020 ). Following transplantation, neural stem cells can differentiate into neural subtype cells, including neurons, astrocytes, and oligodendrocytes, in vivo ( Gage, 2000 ).…”
Section: Introductionmentioning
confidence: 99%
“…This result illustrates the potential of idebenone for treating neurodegenerative diseases including PD. [42] 3α-acetoxyeudesma-1,4(15),11( 13)-trien-12,6aolide [AETO, Figure 2C] is a compound isolated from the leaves of Laurusnobilis L., AETO (0.4, 2, and 10 μM) decreases the active form of caspase-3 and the levels of p53, which were accompanied by increased levels of Bcl-2 in a dose-dependent manner. Flow cytometry and Western blot analyses showed that AETO significantly inhibits DAinduced apoptosis and suppresses intracellular tyrosinase activity, ROS generation, quinoprotein, and SNCA formation.…”
Section: Antioxidant Compounds In Experimental Models Of Pdmentioning
confidence: 99%